About: Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID, Diabetes and Pregnancy Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID, Diabetes and Pregnancy Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID, Diabetes and Pregnancy Study Group
Creator	Di Bartolo, Paolo Festa, Camilla Formoso, Gloria Lapolla, Annunziata Purrello, Francesco Scavini, Marina Sciacca, Laura Sculli, Maria Succurro, Elena Torlone, Elisabetta
Source	Elsevier; Medline; PMC
abstract	Abstract Aim In response to the COVID-19 pandemic, there is a need for substantial changes in the procedures for accessing healthcare services. Even in the current pandemic, we should not reduce our attention towards the diagnosis and treatment of GDM. The purpose of this document is to provide a temporary guide for GDM screening, replacing the current guidelines because of an unfavorable risk/benefit ratio for pregnant women or when usual laboratory facilities are not available. Data Synthesis At the first visit during pregnancy, in all women we must exclude the presence of an %22Overt diabetes%22. The criteria for the diagnosis of overt diabetes are either one fasting plasma glucose ≥ 126 mg/dL, or one random plasma glucose ≥ 200 mg/dL, or one glycated hemoglobin ≥ 6.5% When the screening procedure (OGTT) cannot be safely performed, the diagnosis of GDM is acceptable, if fasting plasma glucose is ≥ 92 mg/dL. In order to consider the impaired fasting glucose an acceptable surrogate for the diagnosis of GDM, the fasting glucose measurement should be performed within the recommended time windows for the risk level (high or medium risk). Conclusions The changes to the screening procedure for GDM reported below are specifically produced in response to the health emergency of the COVID-19 pandemic. Therefore, these recommended changes should cease in effect and replaced by current national guidelines when the healthcare authorities declare the end of this emergency.
has issue date	2020-05-29(xsd:dateTime)
bibo:doi	10.1016/j.numecd.2020.05.023
bibo:pmid	32675009
has license	els-covid
sha1sum (hex)	818f07194e11c63f7eaea505089f413cf6bb37eb
schema:url	https://doi.org/10.1016/j.numecd.2020.05.023
resource representing a document's title	Italian recommendations for the diagnosis of gestational diabetes during COVID-19 pandemic: Position statement AMD-SID, Diabetes and Pregnancy Study Group
has PubMed Central identifier	PMC7258852
has PubMed identifier	32675009
schema:publication	Nutr Metab Cardiovasc Dis
resource representing a document's body	covid:818f07194e11c63f7eaea505089f413cf6bb37eb#body_text
is schema:about of	named entity 'Cardiovascular Diseases' named entity 'CHANGES' named entity 'REDUCE' named entity 'fetal' named entity 'OGTT' named entity 'Pregnancy' named entity 'pregnant women' named entity 'hyperglycemia' named entity 'fetal' named entity 'laboratory testing' named entity 'infection' named entity 'diagnosis' named entity 'pregnant women' named entity 'outpatient setting' named entity 'GDM' named entity 'Oral Glucose Tolerance Test' named entity 'hyperglycaemia' named entity 'scientific evidence' named entity 'gestational weeks' named entity 'AMD' named entity 'glucose tolerance' named entity 'follow-up' named entity 'diabetes' named entity 'sensitivity and specificity' named entity 'long-term' named entity 'OGTT' named entity 'glucose' named entity 'Coronavirus pandemic' named entity 'facilities' named entity 'pandemic' named entity 'procedures' named entity 'laboratory facilities' named entity 'COVID-19 pandemic' named entity 'healthcare services' named entity 'GDM' named entity 'Nutrition' named entity 'healthcare' named entity 'pregnancy' named entity 'ISS' named entity 'postpartum' named entity 'diabetes' named entity 'capillary blood glucose' named entity 'hyperglycemia' named entity 'post-partum' named entity 'GDM' named entity 'laboratory tests' named entity 'insulin' named entity 'OGTT' named entity 'expectant mother' named entity 'diagnostic imaging' named entity 'blood glucose' named entity 'fasting blood glucose' named entity 'AMD' named entity 'fetal growth' named entity 'glucose tolerance' named entity 'diabetes' named entity 'GDM' named entity 'OGTT' named entity 'glucose tolerance' named entity 'congenital malformations' named entity 'OGTT' named entity 'GDM' named entity 'risk/benefit ratio' named entity 'telemedicine' named entity 'diagnostic imaging' named entity 'fetus' named entity 'Istituto Superiore di Sanità' named entity 'gestational age' named entity 'GDM' named entity 'metabolic disorders' named entity 'telemedicine' named entity 'Pregnancy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software